[MYGN] QoQ Quarter Result on 31-Mar-2020 [#Q1]

Stock
[MYGN] Myriad Genetics, Inc.
Announcement Date
05-May-2020
Financial Year
2020
Quarter
31-Mar-2020 [#Q1]
Profit Trend
QoQ- -1,287.95%
YoY- -1,769.57%
Quarter Report
MYGN's Result
MYGN's Financial Summary
View:
Show?
Quarter Result
31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 CAGR
Revenue 154,600 145,200 93,200 164,000 195,100 186,300 215,400 -19.75%
PBT -55,700 -43,700 -58,500 -131,100 -11,400 -22,300 -7,700 271.79%
Tax -11,500 -28,500 -3,000 -15,900 -3,100 -1,700 -3,400 124.49%
NP -44,200 -15,200 -55,400 -115,200 -8,300 -20,600 -4,200 376.81%
Tax Rate - - - - - - - -
Total Cost 198,800 160,400 148,600 279,200 203,400 206,900 219,600 -6.39%
Ratio Analysis
31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 CAGR
NP Margin -28.59 -10.47 -59.44 -70.24 -4.25 -11.06 -1.95 494.18%
Per Share
31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 CAGR
EPS -0.59 -0.20 -0.74 -1.55 -0.11 -0.28 -0.06 355.81%
EPS Diluted -0.59 -0.20 -0.74 -1.55 -0.11 -0.28 -0.06 355.81%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.